- Home
- ATOS vs TSVT Comparison
ATOS vs TSVT Comparison
Compare ATOS & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- TSVT
- Stock Information
- Founded
- ATOS 2009
- TSVT 2021
- Country
- ATOS United States
- TSVT United States
- Employees
- ATOS 10
- TSVT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ATOS Health Care
- TSVT Health Care
- Exchange
- ATOS Nasdaq
- TSVT Nasdaq
- Market Cap
- ATOS 114.5M
- TSVT 128.5M
- IPO Year
- ATOS 2012
- TSVT N/A
- Fundamental
- Price
- ATOS $0.96
- TSVT $2.45
- Analyst Decision
- ATOS Strong Buy
- TSVT Buy
- Analyst Count
- ATOS 3
- TSVT 6
- Target Price
- ATOS $7.00
- TSVT $10.40
- AVG Volume (30 Days)
- ATOS 826.7K
- TSVT 449.7K
- Earning Date
- ATOS 11-12-2024
- TSVT 03-04-2025
- Dividend Yield
- ATOS N/A
- TSVT N/A
- EPS Growth
- ATOS N/A
- TSVT N/A
- EPS
- ATOS N/A
- TSVT N/A
- Revenue
- ATOS N/A
- TSVT $45,620,000.00
- Revenue This Year
- ATOS N/A
- TSVT N/A
- Revenue Next Year
- ATOS N/A
- TSVT $36.09
- P/E Ratio
- ATOS N/A
- TSVT N/A
- Revenue Growth
- ATOS N/A
- TSVT N/A
- 52 Week Low
- ATOS $0.77
- TSVT $2.35
- 52 Week High
- ATOS $2.31
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- ATOS 39.54
- TSVT 36.05
- Support Level
- ATOS $0.81
- TSVT $2.36
- Resistance Level
- ATOS $0.94
- TSVT $2.70
- Average True Range (ATR)
- ATOS 0.05
- TSVT 0.18
- MACD
- ATOS 0.01
- TSVT 0.01
- Stochastic Oscillator
- ATOS 39.13
- TSVT 17.11
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.